Lucas, Minke W.
Versluis, Judith M.
Rozeman, Elisa A.
Blank, Christian U. http://orcid.org/0000-0002-7945-5846
Article History
Accepted: 28 March 2023
First Online: 5 May 2023
Competing interests
: C.U.B. has acted as an advisor to AZ, BMS, GenMab, GSK, Lilly, MSD, Novartis, Pfizer, Pierre Fabre, Roche and Third Rock Ventures, has received research funding from 4SC, BMS, NanoString and Novartis, is a co-founder of and owns shares in Immagene BV and Signature Oncology, and is listed as an inventor on several related patents (including submitted): WO 2021/177822 A1, N2027907 and P091040NL2. The other authors declare no competing interests.